论文信息 - Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men

Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men

Prostate cancer is a significant public health problem in this country. Substantial data support a plausible role for androgens in the etiology of this disease. The human HSD17B3 gene encodes the testicular (or type III) 17β‐hydroxysteroid dehydrogenase enzyme, which catalyzes testosterone biosynthesis in men.

[1] A. Dunaif,et al. Deleterious missense mutations and silent polymorphism in the human 17beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3). , 1998, The Journal of clinical endocrinology and metabolism.

[2] A. Hsing. Hormones and prostate cancer: what's next? , 2001, Epidemiologic reviews.

[3] R. Noble. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. , 1977, Cancer research.

[4] E. Cheng,et al. Endocrinology of the Prostate , 1993 .

[5] C. Franceschi,et al. Evidence for an Association between the SRD5A2 (Type II Steroid 5α-Reductase) Locus and Prostate Cancer in Italian Patients , 2002, Disease markers.

[6] E. Lander,et al. Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility , 1998, European Urology.

[7] N. Makridakis,et al. Multiplex automated primer extension analysis: simultaneous genotyping of several polymorphisms. , 2001, BioTechniques.

[8] K. O. Elliston,et al. Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3 , 1994, Nature Genetics.

[9] M. Pike,et al. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA , 1999, The Lancet.

[10] Taylor Murray,et al. Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.